Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)

SHE:002550 Revenue

Changzhou Qianhong Biopharma CO.,LTD had revenue of 395.73M CNY in the quarter ending September 30, 2026, with 12.03% growth. This brings the company's total for the last twelve months to 1.51B, down -1.52% year-over-year. In the year 2025, Changzhou Qianhong Biopharma CO.,LTD had annual revenue of 1.57B with 2.95% growth. That makes Changzhou Qianhong Biopharma CO.,LTD the 16,605th largest company in the world by revenue and 3,009th in China.

• Revenue (ttm): 1.51B
• Revenue Growth: -1.52%
• P/S Ratio: 5.09
• Revenue / Employee: 1.46M
• Employees: 1,038
• Market Cap: 7.69B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biomedicine 1.53B 97.5%
• Others 39.50M 2.5%

By Geography

Chart

• China 1.21B 76.9%
• Overseas 362.85M 23.1%

Fiscal year ended Dec 31, 2025 See the full SHE:002550 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.57B	45.03M	2.95%
Dec 31, 2024	1.53B	-288.03M	-15.88%
Dec 31, 2023	1.81B	-489.28M	-21.24%
Jan 1, 2023	2.30B	428.61M	22.86%
Jan 1, 2022	1.87B	207.33M	12.43%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error